Practice
Featured experience
$20 billion Electronic Arts acquisition financing
The transaction represents the largest all-cash sponsor take-private in history
Clearlake Capital $5.5 billion Dun & Bradstreet acquisition financing
We advised the agent, lead arrangers and lenders on the financing
Finastra Group $5.32 billion refinancing
We advised the administrative agent, lead arrangers and lenders on the refinancing
Amgen $28.5 billion Horizon Therapeutics acquisition financing
We advised the lender parties on the financing
MultiPlan $4.5 billion debt exchange
We advised an ad hoc group of convertible note holders in connection with the transaction
Rowan $1.2 billion project financing of four data centers
We advised the lenders on the project financing
Over $30 billion of structured credit financings in 2024
We advised on more than 85 structured credit transactions in 2024
Baldwin Group $935 million credit facilities financing
We advised the borrower on the refinancing and amendment
iHeart comprehensive out-of-court debt restructuring
We advised an ad hoc group of noteholders and term loan lenders on the transaction
Royalty Pharma $1.1 billion acquisition of its external manager and $3 billion share repurchase
We are advising Royalty Pharma on the transaction
Veritas Technologies comprehensive debt recapitalization transaction
We advised an ad hoc group of term lenders and noteholders on the transaction
Big Lots sale of substantially all of its assets to Gordon Brothers Retail Partners
We advised Big Lots on the sale
GrafTech International capital raise and exchange transaction
We advised an ad hoc group of noteholders and the first-lien term loan administrative and collateral agent on the transaction
Teoxane proposal to acquire Revance Therapeutics
We are advising Teoxane on the proposed acquisition